 |
|
GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Ji Hee Yu, So Young Park, Da Young Lee, Nan Hee Kim, Ji A Seo
Kidney Res Clin Pract. 2022;41(2):136-149. Published online 2022 Mar 25 DOI: https://doi.org/10.23876/j.krcp.22.001
|
|
Citations to this article as recorded by
 Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes
Djordje S. Popovic, Dimitrios Patoulias, Luigi Gnudi, Christos S. Mantzoros
Metabolism.2024; 151: 155763. CrossRef Moderator's view: after SGLT2i and MRA antagonists, where do we go?
Carmine Zoccali, Jürgen Floege
Clinical Kidney Journal.2024;[Epub] CrossRef Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong, Bryan Chong, Martin Kueh, Chin Meng Khoo, Anurag Mehta, Priyanka Majety, Gowtham R. Grandhi, Georgios K. Dimitriadis, Roger Foo, Nicholas W. S. Chew, Carel W. Le Roux, Mamas A. Mamas
Obesity.2024; 32(5): 840. CrossRef Fasting GLP-1 Levels and Albuminuria Are Negatively Associated in Patients with Type 2 Diabetes Mellitus
Cheol-Won Jang, Tae Yang Yu, Jin Woo Jeong, Se Eun Ha, Rajan Singh, Moon Young Lee, Seungil Ro
Journal of Personalized Medicine.2024; 14(3): 280. CrossRef Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
Merita Rroji, Goce Spasovski
Biomedicines.2024; 12(3): 657. CrossRef Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Nejc Piko, Sebastjan Bevc, Radovan Hojs, Robert Ekart
Pharmaceuticals.2024; 17(4): 418. CrossRef The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes
Jessica Kearney, Luigi Gnudi
Pharmaceutics.2023; 15(5): 1343. CrossRef Obesity-related hypertension and chronic kidney disease: from evaluation to management
Mi-Hyang Jung, Sang-Hyun Ihm
Kidney Research and Clinical Practice.2023; 42(4): 431. CrossRef An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review
Marah Alsayed Hasan, Stanley Schwartz, Victoria McKenna, Richard Ing
Obesity Surgery.2023; 33(9): 2927. CrossRef Kidney Considerations in Pediatric Obesity
Alexandra Sawyer, Evan Zeitler, Howard Trachtman, Petter Bjornstad
Current Obesity Reports.2023; 12(3): 332. CrossRef Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review
Sandra Martínez-Hernández, Martín Muñoz-Ortega, Manuel Ávila-Blanco, Mariana Medina-Pizaño, Javier Ventura-Juárez
Biomedicines.2023; 11(10): 2828. CrossRef The benefits of GLP1 receptors in cardiovascular diseases
Lamija Ferhatbegović, Denis Mršić, Amra Macić-Džanković
Frontiers in Clinical Diabetes and Healthcare.2023;[Epub] CrossRef Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease
Sungmin Kim, Jung Nam An, Young Rim Song, Sung Gyun Kim, Hyung Seok Lee, AJin Cho, Jwa-Kyung Kim, Tomislav Bulum
PLOS ONE.2022; 17(8): e0273004. CrossRef
|